ArticleAsian Pacific journal of cancer prevention : APJCP2023

Overexpression of XRCC1 is Associated with Poor Survival in Patients with Head and Neck Squamous Carcinoma and Has Potential to Be Used as Targeted Therapy by Synthetic Lethality.

Sonu Singh Ahirwar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.